Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement
|Articles|April 1, 2003

Know your options when pursuing denied reimbursement

Author(s)Neil H. Baum, MD

Letters, appeals, and legal action can each help settle denial of compensationclaims

Advertisement

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Advertisement

Related Content

Advertisement
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com

Practical guide to female pelvic organ–sparing radical cystectomy

ByArmine K. Smith, MD,Sarah Azari, MD
January 23rd 2026

ProFam-Risk registry aims to establish model for personalized prostate cancer prevention

ByHannah Clarke
January 22nd 2026

Pearls & Perspectives: Navigating Evidence Gaps and Innovation in OAB Care, With Ariana Smith, MD

ByAmy M. Pearlman, MD,Ariana L. Smith, MD
January 22nd 2026

CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction

ByHannah Clarke
January 21st 2026

FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones

ByHannah Clarke
January 21st 2026

Latest CME

 Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment
Virtual Event

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

February 23, 2026

View more
Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD
Video

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Glenn M. Chertow, MD, MPH; Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Preethi Yerram, MD

View more
Advertisement
Advertisement

Trending on Urology Times

1

Ridwan I. Alam, MD, MPH, discusses combining PHI and MRI to predict prostate cancer risk

2

FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones

3

Targeting BCG resistance in high-risk NMIBC

4

CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction

5

ProFam-Risk registry aims to establish model for personalized prostate cancer prevention

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us